June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.Unlock Stocks

Beachbody, Spectrum Pharmaceuticals And This Industrial Stock Under $1 Insiders Are Aggressively Buying

Published 05/12/2022, 14:39
Updated 05/12/2022, 15:40
© Reuters.  Beachbody, Spectrum Pharmaceuticals And This Industrial Stock Under $1 Insiders Are Aggressively Buying
ASTC
-
SPPI
-

Benzinga - The Dow Jones closed higher by around 35 points on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Spectrum Pharmaceuticals

  • The Trade: Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Director Jeffrey L. Vacirca bought a total of 50,000 shares at an average price of $0.45. To acquire these shares, it cost around $22.5 thousand.
  • What’s Happening: The FDA recently granted a Complete Response Letter (CRL) to Spectrum Pharmaceuticals’ marketing application seeking approval for poziotinib for previously treated locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 20 insertion mutations.
  • What Spectrum Pharmaceuticals Does: Spectrum Pharmaceuticals, incorporated in 1987, is a biopharmaceutical company, develops and commercializes oncology and hematology drug products.

Beachbody Company

  • The Trade: The Beachbody Company, Inc. (NYSE: BODY) Co-Founder and Vice Chairman Jonathan Congdon acquired a total of 250,000 shares at an average price of $0.70. The insider spent around $175.94 thousand to buy those shares.
  • What’s Happening: The company, last month, posted upbeat quarterly results.
  • What Beachbody Company Does: The Beachbody Company, headquartered in El Segundo, California, operates as a health and wellness platform that provides fitness, nutrition, and stress-reducing programs.
Market Volatility Drops Further Following Upbeat Payrolls Report

Don’t forget to check out our premarket coverage here .

Astrotech

  • The Trade: Astrotech Corporation (NASDAQ: ASTC) 10% owner Braden Michael Leonard acquired a total of 190,971 shares at an average price of $0.34. To acquire these shares, it cost around $65.6 thousand.
  • What’s Happening: Astrotech, last month, posted a Q1 loss of $0.05 per share.
  • What Astrotech Does: Astrotech Corporation, incorporated in 1984, operates as a mass spectrometry company worldwide.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.